FdaApplication
ANDA 202132
Identifiers
- fda_app_no: ANDA202132
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED LLC |
| application_type | ANDA |
| approval_date | 2015-09-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORGESTIMATE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; NORGESTIMATE | 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG | TABLET;ORAL-28 |
1 product